Figure 1From: How does infliximab work in rheumatoid arthritis?Efficacy, pharmacokinetics, and antibody incidence of infliximab. Efficacy of infliximab as (a) monotherapy (closed symbols) and (b) in combination with methotrexate (open symbols) based on Paulus 20% criteria; infliximab 1 mg/kg (closed triangle ▲, open triangle △), infliximab 3 mg/kg (closed diamond ◆, open diamond ◇), infliximab 10 mg/kg (closed square ■, open square □), and placebo plus methotrexate (closed circle ●). Arrows indicate the infusion times of infliximab and placebo. (c) Pharmacokinetics of infliximab alone (closed symbols) or with methotrexate (open symbols); infliximab 1 mg/kg (closed triangle ▲, open triangle △) infliximab 3 mg/kg (closed diamond ◆, open diamond ◇), and infliximab 10 mg/kg (closed square ■, open square □). (d) Incidence of anti-infliximab antibodies; infliximab alone (closed symbols) and infliximab plus methotrexate (open symbols). Panels a, b, and c, adapted with permission from Maini et al. [10]; panel d, data from Maini et al. [10]. Copyright 1999. American College of Rheumatology.Back to article page